A new class of Alzheimer’s drugs has been shown to slow the condition’s progression by removing clumps of protein known as amyloid plaques from the brain. However, few countries have approved use of ...

According to a November poll from the Kaiser Family Foundation, one in eight Americans reported taking a GLP-1 drug, which ...

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential ...

The presentation, held at a conference of global economic, political, and scientific leaders, promoted the university’s ...

“According to NHMS (National Health And Morbidity Survey) statistics, vaping among teenagers was 9.8 per cent in 2017, rising sharply to 14.9 per cent in 2022. That is nearly a two-fold increase and ...

Dr Knowles had taken a week-long vacation in an attempt to save his marriage after 22 years of alcoholism. But instead of ...

Neuroscientists are tracking the brain activity that underlies a cognitive breakthrough and unraveling how it might boost ...

Inside a wellness spa in Chicago’s River North neighborhood, a video of Gwyneth Paltrow plays on a quiet loop near the ...

Did you know that the typical child spends a massive portion of their day, over 7 hours, busy with activities that include a ...

Many patients taking obesity and diabetes drugs like Ozempic and Wegovy have found its benefits go beyond weight loss.

Methamphetamine doesn't just spike levels of the pleasure-inducing hormone dopamine in the reward pathways of the brain—it ...

A new study published in Translational Psychiatry provides evidence that chronic heroin addiction impairs the neural networks ...